BlackRock’s Titan Pharmaceuticals TTNP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-6
| Closed | -$29 | – | 5639 |
|
|
2025
Q3 | $29 | Hold |
6
| – | – | ﹤0.01% | 5422 |
|
|
2025
Q2 | $25 | Hold |
6
| – | – | ﹤0.01% | 5431 |
|
|
2025
Q1 | $21 | Buy |
+6
| New | +$22 | ﹤0.01% | 5401 |
|
|
2024
Q1 | – | Sell |
-3
| Closed | -$25 | – | 5390 |
|
|
2023
Q4 | $25 | Hold |
3
| – | – | ﹤0.01% | 5351 |
|
|
2023
Q3 | $28 | Hold |
3
| – | – | ﹤0.01% | 5421 |
|
|
2023
Q2 | $39 | Hold |
3
| – | – | ﹤0.01% | 5476 |
|
|
2023
Q1 | $50 | Hold |
3
| – | – | ﹤0.01% | 5544 |
|
|
2022
Q4 | $47 | Hold |
3
| – | – | ﹤0.01% | 5737 |
|
|
2022
Q3 | $0 | Hold |
3
| – | – | ﹤0.01% | 5933 |
|
|
2022
Q2 | $0 | Hold |
3
| – | – | ﹤0.01% | 5986 |
|
|
2022
Q1 | $0 | Hold |
3
| – | – | ﹤0.01% | 5908 |
|
|
2021
Q4 | $0 | Hold |
3
| – | – | ﹤0.01% | 5860 |
|
|
2021
Q3 | $0 | Hold |
3
| – | – | ﹤0.01% | 5694 |
|
|
2021
Q2 | $0 | Hold |
3
| – | – | ﹤0.01% | 5567 |
|
|
2021
Q1 | $0 | Hold |
3
| – | – | ﹤0.01% | 5352 |
|
|
2020
Q4 | $0 | Hold |
3
| – | – | ﹤0.01% | 5177 |
|
|
2020
Q3 | $0 | Hold |
3
| – | – | ﹤0.01% | 5165 |
|
|
2020
Q2 | $1K | Hold |
3
| – | – | ﹤0.01% | 4977 |
|
|
2020
Q1 | $0 | Hold |
3
| – | – | ﹤0.01% | 5083 |
|
|
2019
Q4 | $0 | Hold |
3
| – | – | ﹤0.01% | 5071 |
|
|
2019
Q3 | $0 | Hold |
3
| – | – | ﹤0.01% | 5080 |
|
|
2019
Q2 | $2K | Hold |
3
| – | – | ﹤0.01% | 4926 |
|
|
2019
Q1 | $3K | Hold |
3
| – | – | ﹤0.01% | 4795 |
|
|
2018
Q4 | $2K | Hold |
3
| – | – | ﹤0.01% | 4847 |
|
|
2018
Q3 | $2K | Hold |
3
| – | – | ﹤0.01% | 4900 |
|
|
2018
Q2 | $10K | Sell |
3
-14
| -82% | -$46.9K | ﹤0.01% | 4750 |
|
|
2018
Q1 | $64K | Sell |
17
-1
| -6% | -$4.18K | ﹤0.01% | 4410 |
|
|
2017
Q4 | $87K | Buy |
18
+1
| +6% | +$6.22K | ﹤0.01% | 4356 |
|
|
2017
Q3 | $109K | Sell |
17
-1
| -6% | -$6.19K | ﹤0.01% | 4355 |
|
|
2017
Q2 | $123K | Sell |
18
-205
| -92% | -$1.91M | ﹤0.01% | 4363 |
|
|
2017
Q1 | $2.65M | Buy |
+223
| New | +$3.14M | ﹤0.01% | 3575 |
|
|
2016
Q4 | – | Hold |
0
| – | – | – | 3602 |
|
|
2016
Q3 | – | Hold |
0
| – | – | – | 3529 |
|
|
2016
Q2 | – | Hold |
0
| – | – | – | 3545 |
|
Other funds holding TTNP
CA
GWSA
CSC
DJSG
BlackRock's TTNP Position: Q4 2025 in Review
BlackRock sold out of Titan Pharmaceuticals (TTNP) in Q4 2025, closing a stake of 6 shares — an estimated $29 sold.
BlackRock first reported a position in TTNP in Q1 2017 and held it in 31 quarters. The position peaked at $2.65M in Q1 2017. 4 funds tracked by Wall St. Rank hold TTNP as of Q4 2025.
- BlackRock reported no remaining Titan Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
- BlackRock sold 6 Titan Pharmaceuticals shares in Q4 2025, an estimated $29.
- BlackRock first reported a position in Titan Pharmaceuticals in Q1 2017 and held it in 31 quarters.
- BlackRock's Titan Pharmaceuticals position peaked at $2.65M in Q1 2017.
- 4 funds tracked by Wall St. Rank held Titan Pharmaceuticals as of Q4 2025.
Based on BlackRock's 13F filing for Q4 2025, filed 12 Feb 2026.